BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1314 related articles for article (PubMed ID: 9850056)

  • 1. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.
    Tamm I; Wang Y; Sausville E; Scudiero DA; Vigna N; Oltersdorf T; Reed JC
    Cancer Res; 1998 Dec; 58(23):5315-20. PubMed ID: 9850056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin.
    Geller J; Petak I; Szucs KS; Nagy K; Tillman DM; Houghton JA
    Clin Cancer Res; 2003 Dec; 9(17):6504-15. PubMed ID: 14695155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bax membrane insertion during Fas(CD95)-induced apoptosis precedes cytochrome c release and is inhibited by Bcl-2.
    Murphy KM; Streips UN; Lock RB
    Oncogene; 1999 Oct; 18(44):5991-9. PubMed ID: 10557088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
    Hasenjäger A; Gillissen B; Müller A; Normand G; Hemmati PG; Schuler M; Dörken B; Daniel PT
    Oncogene; 2004 Jun; 23(26):4523-35. PubMed ID: 15064710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2.
    Dirsch VM; Stuppner H; Vollmar AM
    Cancer Res; 2001 Aug; 61(15):5817-23. PubMed ID: 11479221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a caspase-2 isoform that behaves as an endogenous inhibitor of the caspase cascade.
    Droin N; Beauchemin M; Solary E; Bertrand R
    Cancer Res; 2000 Dec; 60(24):7039-47. PubMed ID: 11156409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis.
    Bantel H; Engels IH; Voelter W; Schulze-Osthoff K; Wesselborg S
    Cancer Res; 1999 May; 59(9):2083-90. PubMed ID: 10232592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis.
    Engels IH; Stepczynska A; Stroh C; Lauber K; Berg C; Schwenzer R; Wajant H; Jänicke RU; Porter AG; Belka C; Gregor M; Schulze-Osthoff K; Wesselborg S
    Oncogene; 2000 Sep; 19(40):4563-73. PubMed ID: 11030145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
    Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y
    Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis.
    Perkins CL; Fang G; Kim CN; Bhalla KN
    Cancer Res; 2000 Mar; 60(6):1645-53. PubMed ID: 10749135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phytosphingosine induces apoptotic cell death via caspase 8 activation and Bax translocation in human cancer cells.
    Park MT; Kang JA; Choi JA; Kang CM; Kim TH; Bae S; Kang S; Kim S; Choi WI; Cho CK; Chung HY; Lee YS; Lee SJ
    Clin Cancer Res; 2003 Feb; 9(2):878-85. PubMed ID: 12576463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-linked IAP is a direct inhibitor of cell-death proteases.
    Deveraux QL; Takahashi R; Salvesen GS; Reed JC
    Nature; 1997 Jul; 388(6639):300-4. PubMed ID: 9230442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K; Douglas L; Delaney A; Houghton JA
    Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis.
    Fulda S; Meyer E; Friesen C; Susin SA; Kroemer G; Debatin KM
    Oncogene; 2001 Mar; 20(9):1063-75. PubMed ID: 11314043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM; Turchi JJ
    Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
    Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L
    Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent.
    Ochs K; Kaina B
    Cancer Res; 2000 Oct; 60(20):5815-24. PubMed ID: 11059778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.
    Yang L; Mashima T; Sato S; Mochizuki M; Sakamoto H; Yamori T; Oh-Hara T; Tsuruo T
    Cancer Res; 2003 Feb; 63(4):831-7. PubMed ID: 12591734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel isoform of TUCAN is overexpressed in human cancer tissues and suppresses both caspase-8- and caspase-9-mediated apoptosis.
    Yamamoto M; Torigoe T; Kamiguchi K; Hirohashi Y; Nakanishi K; Nabeta C; Asanuma H; Tsuruma T; Sato T; Hata F; Ohmura T; Yamaguchi K; Kurotaki T; Hirata K; Sato N
    Cancer Res; 2005 Oct; 65(19):8706-14. PubMed ID: 16204039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-xES, a BH4- and BH2-containing antiapoptotic protein, delays Bax oligomer formation and binds Apaf-1, blocking procaspase-9 activation.
    Schmitt E; Paquet C; Beauchemin M; Bertrand R
    Oncogene; 2004 May; 23(22):3915-31. PubMed ID: 15048082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.